We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
JH...good points..I originally got in very low...50-70 region...I normally sell on any placing news....I sold half this time and kept half due to the stemprint situation...then bought all the way down from 165 to 142...and now no more funds. Like Sk...risk of a deal in background. Hopefully shorts will be closed coming weeks.
JH.. good points. I think one thing we are not focussing on here is the FOMO on a good entry point before cut off. For a long time all people were interested in was the stemprint news. When that wasnt forthcoming the SP suffered. Good news became bad news and good rns were ignored. Now I feel the shoe is on the other foot. We have a time frame and any news (No matter how trivial )will make this jump. Example being 10-12% we did with the good Drs interview. Many dont realise but the rerate is beginning and this will continue for the next 4 weeks. I dont think anyone will want to risk getting in when this is over £2.50-£3 so expect consistent rises now. Only thing holding us back is nasdaq but the bulls seem to be winning in last few sessions and the shorts will close soon. I looked at latest shareholder register and there is only a 14.9% free float (just over 28 million shares). Hence I expect it to fly soon!
Totally agree. Anything could have happened here. Too much risk for me too. I was lucky with tils. My eldest son put me onto them ages ago so my average was about 106 until last week. I bought quite a few more last week and might buy more this week. Anything under 150 is the bargain of the century imho. 1 month and we will nearly double our money is my guess. And it is a guess lol
jh2704, Many good points the only problem with selling and taking a temporary "paper loss which was quite large" and re investing at a lower price was the StemprintER situation and far to risky to take. The BOD was very quite and could have been busy doing a deal (typical with my luck haha )and a special dividend announced whilst out.
SOS
GLA
Agreed
Muddy waters are usually successful at shorting cos the companies they target are usually really dodgy fraudulent companies
@shareoursuccess....shorters thrive in a share where the board are in a closed period/ cant communicate. Once we announced we had 5 NDAs in place it was an open goal for them. Now that there is a published timeline they will have no option but to close their positions. So it will be volatile over the next month imho BUT the trajectory is definitely up until end Oct (just my reading of the situation I admit)
What I have learned is to sell out of any share once the shorters get busy. They always seem to succeed in driving the price down...and I will get a better price later. I have seen this with PMO/ TLW/ MTRO/ BOO to name but a few. I am up 25% in BOO (and more to come with next weeks results) in about a month...all because of that damning Guardian report into Leicester working practices in the BOO supply chain.
TILS imho is the same now...shorters drove it down (because they could!)...Winnifrith even went public and said he was going to short TILS), and now they have to exit and it will rise.
The exception (for me) is Muddywaters..when they short something they are usually correct (NMC/ BUR). I got out of NMC (luckily for me) but many of my friends didnt.
SOS.. well said. Cant disagree with your worries about the large drop. I think much of it is to do with the placing, shorting and general state of economy. Not to mention the 6 week window. I dont believe the market is rational at the moment. For instance we did +12% on news of our ceo going on telly (to tell us everything we already know) and we lost 2% on news we are doing a covid trial on actual patients with results before xmas. You explain that?!
Finally One thing I have learnt in my short time on stocks is that everything is about sentiment. Look at some covid testing stocks recently that have done upwards of 20-30% on zero news or outcome. I think stemprint will change sentiment and the FOMO is what will drive in the herds. I agree Nasdaq is key and all of us here will be watching it very closely over the coming weeks. Roker has assured me that the USA folks understand what they're doing so I am expecting them to come good at some stage.
shirazkhan, I'm sure you know I respect your views, and love your optimism and passion for Tiziana. Only time will tell where the SP will be at record date, this currently depends solely on the Nasdaq if the LSE was leading I would be far more optimistic (pre record date).
I have no doubt the the already paid for (NOT FREE) Accustem share will be a very rewarding additional (the reason why lots of people invested in Tils) and would take the combined investment price beyond the very important £2 level therefore taking practically all investors into profit territory ( Including myself having never seen a blue figure on Tils investment so far)
I have never doubted the company / BOD and the outcome of my investment, (Accustem will settle that shortly), what I have questioned and will continue to voice my opinion even if its not agreed with or welcomed is the current SP even if its deemed "moaning or complaining"
When a share price crashes 30% + upon ZERO bad news and plenty positive news its alarming and I don't view it as "great price to buy it at a bargain price" because if it happens now it could happen in the future especially when looking long term and without the cushion of a Accustem demerger to bail out the SP.
We all have differing views of what / why / how come the price has crashed and the BB is a platform to share them
Like I've said before I would love to be proved wrong on the SP over the next few weeks and beyond
SOS
GLA
SOS- I respect your view as you are basing that on the fact you have been in the red for much of your time on this board. Seen all of the pain and none of the gain, with plenty of false rises so your view is warranted.
In this case I think you are being harsh. I dont share your view that the rise will be slow and painful. It will be very quick and it will happen in the next 3 weeks.
Reason. Tils mcap is £270 million, accustem is worth minimum $280 million according to world renowned analyst. Those on record date get 1:1 shares. You dont have to be a rocket scientist to see where this is going.
I am doing some reading into immune modulators and so far I can see a compelling case for a successful foralumab trial (see article I posted earlier). I agree with wisha that joint therapy with immune modulators, antivirals and immumnosuppresive corticosteroids like dexamethasone is the way forward. The latter of these has already proved beneficial and is point used in primary care. If foralumab shows clinical benefit then wow. Then we have a trial starting in january for IL6 (again covid-19). Plus you have 2 trials starting imminently in some of the biggest revenue generating pharma indications in the world. All for £1.42 Thats just mental. Only for a few more days. The market will correct itself.